| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $310.6M | +16.4% |
| Cost of Revenue | $132.0M | +52.9% |
| Gross Profit | $178.6M | -1.1% |
| R&D Expense | $201.4M | -4.4% |
| SG&A Expense | $81.4M | +5.4% |
| Operating Income | -$318.3M | -9.6% |
| Pre-tax Income | -$278.9M | -4.0% |
| Income Tax | $792K | +17.3% |
| Net Income | -$279.7M |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.1M | -41.3% |
| Short-term Investments | $583.2M | +30.7% |
| Accounts Receivable | $130.1M | -3.4% |
| Current Assets | $904.4M | +1.7% |
| Total Assets | $1.04B | -5.9% |
| Current Liabilities | $102.3M | -24.8% |
| Total Liabilities | $164.9M | -4.9% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.4M | +46.1% |
| Capital Expenditures | $25.3M | -64.2% |
| Investing Cash Flow | -$66.6M | -211.1% |
| Financing Cash Flow | $11.3M | +1718.7% |
| Free Cash Flow | -$87.6M | +52.9% |
| -4.0% |
| EPS (Basic) | -$2.34 | +4.5% |
| EPS (Diluted) | -$2.34 | +4.5% |
| Stockholders' Equity |
| $873.4M |
| -6.1% |